GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kimia Biosciences Ltd (BOM:530313) » Definitions » Other Current Liabilities

Kimia Biosciences (BOM:530313) Other Current Liabilities : ₹0.00 Mil (As of . 20)


View and export this data going back to 2017. Start your Free Trial

What is Kimia Biosciences Other Current Liabilities?

Kimia Biosciences's other current liabilities for the quarter that ended in . 20 was ₹0.00 Mil.


Kimia Biosciences Other Current Liabilities Historical Data

The historical data trend for Kimia Biosciences's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kimia Biosciences Other Current Liabilities Chart

Kimia Biosciences Annual Data
Trend
Other Current Liabilities

Kimia Biosciences Semi-Annual Data
Other Current Liabilities

Kimia Biosciences Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.


Kimia Biosciences Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Kimia Biosciences's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Kimia Biosciences (BOM:530313) Business Description

Traded in Other Exchanges
N/A
Address
Netaji Subhash Place, 974, 9th Floor, Aggarwal Millenium Tower-II, Pitampura, New Delhi, IND, 110 034
Kimia Biosciences Ltd is a company engaged in the manufacturing of bulk drugs. Some of the company's products include Azelnidipine, Deflazacort, Oxaceprol, Seratodast, and Tretinoin among others. Its only operating segment being Pharmaceuticals.

Kimia Biosciences (BOM:530313) Headlines

No Headlines